Clinical Trials Directory

Trials / Unknown

UnknownNCT04260282

Microbiome and Exacerbations in Neutrophilic Asthma

Exacerbations in Neutrophilic Asthma: Influence of Bronchial Microbiome

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Neutrophilic asthma (NA) is the least known severe asthma phenotype. It is associated with more exacerbations, worse control and impaired lung function. One of its possible etiologies is bronchial infections. The study of bronchial microbiology and its relationship with exacerbations is a new line of research. Objectives: 1) To analyze bronchial microbiome in patients with AN and non-neutrophilic (ANN), with frequent exacerbations and without exacerbations. 2) To relate the presence of bronchial infections with differences in the microbiome. 3) Correlate the characteristics of the microbiome with other evidence used in exacerbations. Methods: Prospective study involving 40 non-smoking asthmatics without bronchiectasis (20 with AN and 20 with ANN). Of these, 10 in each group will have frequent exacerbations (\>2 rounds of systemic steroids in the last year, of \>3 days each) and 10 non- frequent exacerbations. AN will be defined as \>65% neutrophils in stable phase sputum. All patients will have two stable visits in which clinical variables, asthma control, lung function and induced sputum samples will be collected (for analysis of bronchial inflammatory cell count and for the study of the microbiome by 16 subunit rRNA). Specific Immunoglobulin A (IgA) for Chlamydia Pneumoniae will be determined. In exacerbations, sputum samples will be collected for culture and nasopharyngeal smears for the study of major respiratory viruses and bacteria by multiple polymerase chain reaction.

Detailed description

See above

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPolymerase Chain Reaction (PCR) for viruses and bacteria in nasal swabPCR for viruses and bacteria in nasal swab
DIAGNOSTIC_TESTInduced sputum microbiomeMicrobiome in induced sputum

Timeline

Start date
2021-01-01
Primary completion
2024-01-01
Completion
2025-01-01
First posted
2020-02-07
Last updated
2023-01-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04260282. Inclusion in this directory is not an endorsement.